Likun Gong

机构：Shenyang Pharmaceutical University, Nanjing University of Chinese Medicine, Chinese Academy of Sciences, Fudan University, Shanghai Institute of Materia Medica, University of Chinese Academy of Sciences, East China Normal University, Academia Sinica · ORCID：0000-0002-1896-4188

发表论文 115 篇 · 总被引 2198 次 · h-index 28

代表论文

• Multifunctional Tribovoltaic Coating for Self‐Powered In Situ Sensing with Exceptional Tribological Robustness and Charge Transport (2025 · Advanced Functional Materials · 被引 47)
• Exploring Regulatory Frameworks for Exosome Therapy: Insights and Perspectives (2025 · Health care science · 被引 42)
• INHBA promotes tumor growth and induces resistance to PD-L1 blockade by suppressing IFN-γ signaling (2024 · Acta Pharmacologica Sinica · 被引 21)
• Zexie-Baizhu Decoction ameliorates non-alcoholic fatty liver disease through gut-adipose tissue crosstalk (2024 · Journal of Ethnopharmacology · 被引 18)
• A nanobody-enzyme fusion protein targeting PD-L1 and sialic acid exerts anti-tumor effects by C-type lectin pathway-mediated tumor associated macrophages repolarizing (2025 · International Journal of Biological Macromolecules · 被引 14)
• GFPBW1, a β-glucan from Grifola frondosa as vaccine adjuvant: APCs activation and maturation (2024 · Acta Pharmacologica Sinica · 被引 12)